Suppression of intestinal polyp development in ApcMin/+ mice through inhibition of P-glycoprotein using verapamil

European Journal of Cancer Prevention

Volumn 22, Issue 1, 2013, Pages 8-10

  Fujimoto, Kyoko ^a   Fujii, Gen ^b   Mutoh, Michihiro ^b   Yasunaga, Masa ^c   Tanaka, Hiromitsu ^a   Wada, Morimasa ^c  

^a NAGASAKI INTERNATIONAL UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

chemoprevention; colorectal cancer; Mdr1a protein; verapamil

Indexed keywords

GLYCOPROTEIN P INHIBITOR; MULTIDRUG RESISTANCE PROTEIN; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DNA MODIFICATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; GENE PRODUCT; GENOTYPE; INTESTINE POLYP; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SURVIVAL RATE; TRANSCRIPTION INITIATION;

ADENOMATOUS POLYPOSIS COLI; ANIMALS; DISEASE MODELS, ANIMAL; GENES, APC; INTESTINAL POLYPS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; P-GLYCOPROTEIN; VERAPAMIL;

EID: 84870981880     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e328353ede8     Document Type: Article

References (9)

1. Cornwell MM, Pastan I, Gottesman MM (1987). Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J Biol Chem 262: 2166-2170
2. Fujimoto H, Higuchi M,Watanabe H, Koh Y, Ghosh AK, Mitsuya H, et al. (2009). P-glycoprotein mediates efflux transport of darunavir in human intestinal Caco-2 and ABCB1 gene-transfected renal LLC-PK1 cell lines. Biol Pharm Bull 32:1588-1593
3. Haas H, Igarashi T (1968). Comparative studies in the heart-lung-preparation of dog on the action spectrum of verapamil, quinidine and some alpha- and beta-sympatholytics as well as the effect of adrenaline. Arzneimittelforschung 18:1373-1380
4. Herszenyi L, Farinati F, Miheller P, Tulassay Z (2008). Chemoprevention of colorectal cancer: Feasibility in everyday practice? Eur J Cancer Prev 17:502-514
5. Mochida Y, Taguchi K, Taniguchi S, Tsuneyoshi M, Kuwano H, Tsuzuki T, et al. (2003). The role of P-glycoprotein in intestinal tumorigenesis: Disruption of mdr1a suppresses polyp formation in ApcMin/+ mice. Carcinogenesis 24:1219-1224
6. Munić V, Kelnerić Z, Mikac L, Haber EV (2010). Differences in assessment of macrolide interaction with human MDR1 (ABCB1, P-gp) using rhodamine-123 efflux, ATPase activity and cellular accumulation assays. Eur J Pharm Sci 41:86-95
7. Qian XD, Beck WT (1990). Binding of an optically pure photoaffinity analogue of verapamil, LU-49888, to P-glycoprotein from multidrug-resistant human leukemic cell lines. Cancer Res 50:1132-1137
8. Tanigawara Y (2000). Role of P-glycoprotein in drug disposition. Ther Drug Monit 22:137-140
9. Yamada T, Mori Y, Hayashi R, Takada M, Ino Y, Naishiro Y, et al. (2003). Suppression of intestinal polyposis in Mdr1-deficient ApcMin/+ mice. Cancer Res 63:895-901